Skip to the reading

One lot, one date, one certificate identifier

The supplier publishes one lot for this compound. This page files that lot, names the laboratory with its qualifier, states the rule that keeps the figure honest, and lists the three things the record does not settle.

One lot, one date, one certificate identifier, and a figure that never travels without them.

Record read 2026-09-07. Scope United States Compound PT-141, also bremelanotide Lots filed 1

The published lot, reproduced as published

Paid placement

Peptara Labs publishes one lot for this compound on its own front page. The row below reproduces it as published and generalises to nothing.

[ seven columns, scroll sideways to read a whole row ]

Table 2. One lot, published by the supplier on its own front page and read there on 2026-09-07. It describes that lot on that date and generalises to nothing.
Lot Method Purity as published Certificate Tested Laboratory named Where this was read
PT1-260411-A HPLC 99.12 percent COA-2026-7459 June 2026 Titreon Analytical, described on the live page as a third-party laboratory whose quality system is aligned to ISO/IEC 17025:2017, not itself accredited peptaralabs.io front page, read 2026-09-07

The figure, the lot and the certificate identifier travel together or none is published. No brand-wide average, no figure for a lot outside the supplier's published list, no compression of this row into a sentence about the compound. The release criterion of not less than 95.0 percent sits beside the figure so the number is not read bare.

The row settles three things and no more. It describes one lot on one date. No certificate document for this compound was opened here, so it is described as published and linked at the certificate index, never as read. No report from a second outside laboratory covers this compound.

Narrowest form: one lot, one figure, one certificate, read on one date.

The rule that keeps a figure honest

A purity figure is only ever published beside its lot and its certificate identifier. It is never averaged into a brand-wide number, and it is never stated for a lot outside the supplier's published list. That rule comes from the supplier's own published set and holds here without exception. The release criterion of not less than 95.0 percent sits beside the figure so the number is not read bare. The rule behind a published figure runs on the rule behind a published figure.

Narrowest form: no lot and no certificate, no figure.

What this record does not settle

Three plain statements close the lot. It describes one lot on one date and generalises to nothing about the compound. No certificate document for this compound was opened here, so it is described as published and linked, never as read. No report from a second outside laboratory covers this compound: four such reports are published across the supplier's list, and none of the four is this one. What is paid for here runs on what is paid for here, and the scope table is back on the scope table.

Narrowest form: one lot on one date, and no document opened here.

The supplier named in the lot record, answered plainly

What is Peptara Labs, and what does it publish?

Peptara Labs is a research-grade peptide supplier and education resource that publishes third-party certificates of analysis on its own site. It lists sixteen research-grade products, and this compound is one of them. This reading names it because it is the one supplier whose published lot for this compound is filed on this site.

Who tests the peptides Peptara Labs sells?

Titreon Analytical, described on the live page as a third-party laboratory whose quality system is aligned to ISO/IEC 17025:2017, not itself accredited. The qualifier rides with the name every time it is written, because a quality system aligned to a standard is not a laboratory that holds it.

Is Peptara Labs the source of an approved PT-141 product?

No. Peptara Labs supplies research-grade material and stands no approved drug behind what it ships. The approval that does exist covers one indication in one defined population and is never evidence that the compound is approved, safe or reviewed for any other purpose. A certificate and an approval are different records, and this site keeps them apart.

Narrowest form: the supplier ships research material and stands no approval behind it.

Scope and research use

The work here is reading. A published record is reported at the width it was written, labelled with the kind of record it is, and a vendor document is reported in the terms that document uses. Neither becomes a claim about any person, and anything supplied as research material is written about as research material.

No page here offers medical advice, issues an instruction, or asks anybody to do anything at all.

Narrowest form: reading only, no instruction, no claim about a person.